logo
Quick Facts
  

Norwegian Cruise Closes $3.03 Bln Acquisition Of Prestige

By RTTNews Staff Writer   ✉   | Published: | Follow Us On Google News

Norwegian Cruise Line Holdings Ltd (NCLH) Wednesday completed its about $3.03 billion acquisition of Prestige Cruises International Inc. Prestige operates in the upscale cruise segment and is the parent company of Oceania Cruises and Regent Seven Seas Cruises.

With this acquisition, Norwegian Cruise operates a portfolio of brands that span all market segments in the cruise industry, from contemporary to upper-premium to luxury.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Boston Scientific Boosts FY24 Outlook - Update
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...
Roche Q1 Sales Down, Confirms FY24 View; Stock Down
Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.
Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution
Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.
Biotechnology Weekly Update - April 24, 2024

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Latest Updates on COVID-19
Read More
COVID-19: Drugs in Development
RELATED NEWS
Follow RTT
Copyright © 2024 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap